Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients

Archives of Dermatology

Volumn 140, Issue 9, 2004, Pages 1079-1085

  Fortina, Anna Belloni ^a   Piaserico, Stefano ^a   Caforio, Alida L P ^a   Abeni, Damiano ^b   Alaibac, Mauro ^a   Angelini, Annalisa ^a   Iliceto, Sabino ^a   Peserico, Andrea ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; PREDNISONE;

ADULT; AGING; ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; CLASSIFICATION; COMBINATION CHEMOTHERAPY; DOSE CALCULATION; FEMALE; GENDER; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK FACTOR; SKIN TYPE; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; VERRUCA VULGARIS; WEIGHTED LINEAR COMBINATION;

ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SKIN NEOPLASMS; STATISTICS, NONPARAMETRIC; TRANSPLANTATION IMMUNOLOGY;

EID: 4544306598     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.9.1079     Document Type: Article

References (35)

1. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP. Risk of neoplasia in renal transplant patients. Lancet. 1995;346:403-406.
2. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348:1681-1691.
3. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am. 1993;7:431-445.
4. Ong CS, Keogh AM, Kossard S, Macdonald PS, Spratt PM. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol. 1999;40:27-34.
5. Hartevelt MM, Bouwes Bavinck JN, Kootte AMM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation. 1990;49:506-509.
6. Lampros TD, Cobanoglu A, Parker F, Ratkovec R, Norman DJ, Hershberger R. Squamous and basal cell carcinoma in heart transplant recipients. J Heart Lung Transplant. 1998;17:586-591.
7. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40:177-186.
8. Belloni Fortina A, Caforio ALP, Piaserico S, et al. Skin cancer in heart transplant recipients: frequency and risk factor analysis. J Heart Lung Transplant. 2000;19:249-255.
9. Ferràndiz C, Fuente MJ, Ribera M, et al. Epidermal dysplasia and neoplasia in kidney transplant recipients. J Am Acad Dermatol. 1995;33:590-596.
10. Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, et al. Relations between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med. 1991;325:843-848
11. Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transptantation. 1996;61:715-721.
12. Dantal J, Hourmant M, Cantarovich D, Giral M, Blancho G, Dreno B, Effects of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet. 1998;351:623-628.
13. Caforio ALP, Belloni Fortina A, Piaserico S, et al. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation. 2000;102(19 suppl 3):111222-111227.
14. Ducloux D, Carron PL, Motte G, et al. Lymphocyte subsets and assessment of cancer risk in renal transplant recipients. Transpl Int. 2002;15:393-396.
15. Naldi L, Fortina AB, Lovati S, et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients: a registry-based study. Transplantation. 2000;70:1479-1484.
16. Lever WF, Schaumburg-Lever G. Histopathology of the Skin. 7th ed. Philadelphia, Pa: JB Lippincott; 1990.
17. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869-871.
18. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardisation of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transplant. 1990;9:587-593.
19. Mardia KV, Kent JT, Bibby JM. Multivariate Analysis. London, England: Academic Press; 1979.
20. Norusis MJ. SPSS for Windows Professional and Advanced Statistics, Release 11. Chicago, III: SPSS Inc; 2002.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
22. Lawless JF. Statistical Models and Methods for Lifetime Data. Chichester, England: John Wiley & Sons; 1982.
23. Roeger LS, Sheil AGR, Disney APS, Mathew TH, Amiss N. Risk factors associated with the development of squamous cell carcinoma in immunosuppressed renal transplant recipients. Clin Transplant. 1992;6:202-211.
24. Kwa RE, Campana K, Moy RL. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;26:1-26.
25. Kripke ML. Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst. 1974;53:1333-1336.
26. Haeffner AC, Zepter K, Elmets CA, Wood GS. Analysis of tumor-infiltrating lymphocytes in cutaneous squamous cell carcinoma. Arch Dermatol. 1997;133:585-590.
27. Gatter KC, Morris HB, Roach B, et al. Langerhans cells and T cells in human skin tumors: an immunohistological study. Histopathology. 1984;8:229-244.
28. Bergfelt L, Emilson A, Lindberg M, Scheynius A. Quantitative and 3-dimensional analysis of Langerhans cells in basal cell carcinoma: a comparative study using light microscopy and confocal laser scanning microscopy. Br J Dermatol. 1994;130:273-280.
29. Taylor SR, Griffiths CEM, Brown MD, Swanson NA, Nickoloff BJ. Constitutive absence and interferon-gamma-induced expression of adhesion molecules in basal cell carcinoma. J Am Acad Dermatol. 1990;22:721-726.
30. Ramsay HM, Fryer AA, Reece S, Smith AG, Harden PN. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis. 2000;36:167-176.
31. Espana A, Martinez-Gonzalez MA, Garcia-Granero M, Sanchez-Carpintero I, Rabago G, Herreros J. A prospective study of incident nonmelanoma skin cancer in heart transplant recipients. J Invest Dermatol. 2000;115:1158-1160.
32. Rosso S, Zanetti R, Martinez C, et al. The multicentre south European study "Helios," II: different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer. 1996;73:1447-1454.
33. Amstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001;63:8-18.
34. Zanetti R, Rosso S, Martinez C, et al. The multicentre south European study "Helios," I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer. 1996;73:1440-1446.
35. Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and nonmelanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol. 2000;61:289-297.